Net Change In Cash - Epizyme Inc (F:EPE) - Alpha Spread
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Epizyme Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Epizyme Inc
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
E
Epizyme Inc
F:EPE
Net Change in Cash
-$9.1m
CAGR 3-Years
25%
CAGR 5-Years
-57%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Change in Cash
$4.4B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
29%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$2.9B
CAGR 3-Years
-17%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$24.9B
CAGR 3-Years
-115%
CAGR 5-Years
-40%
CAGR 10-Years
-33%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-48%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$21.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Epizyme Inc's Net Change in Cash?
Net Change in Cash
-9.1m USD

Based on the financial report for Jun 30, 2022, Epizyme Inc's Net Change in Cash amounts to -9.1m USD.

What is Epizyme Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-57%

Over the last year, the Net Change in Cash growth was 75%. The average annual Net Change in Cash growth rates for Epizyme Inc have been 25% over the past three years , -57% over the past five years .

Back to Top